Nonetheless, we found a reduced suppression of Ki67 for TP53-mutated tumours within the poor responder group, which supports the finding by Ellis et al. 6 who reported a greater suppression of Ki67 by letrozole in WT than TP53-mutated tumours. Here, TP53 is linked to neoplasm.